Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 156 entries
View as:

Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection

Phase: N/A Priority: Normal
NCT ID: NCT04466982 Org: User:
Start: 07/02/20 End: 01/31/22 Due: 01/31/23

Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT03113773 Org: User:
Start: 05/11/17 End: 02/21/19 Due: 02/21/20

Ultrasound Localization in Thoracic Surgery - is Radiation Reduction Achievable?

Phase: N/A Priority: Normal
NCT ID: NCT05968950 Org: User:
Start: 09/01/23 End: 12/31/24 Due: 12/31/25

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00602082 Org: User:
Start: 08/31/05 End: 12/31/09 Due: 12/31/10

Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT00293072 Org: User:
Start: 03/31/02 End: 05/31/05 Due: 05/31/06

Regeneration in Cervical Degenerative Myelopathy

Phase: N/A Priority: Normal
NCT ID: NCT04631471 Org: User:
Start: 12/22/21 End: 09/01/26 Due: 09/01/27

Alemtuzumab for ANCA Associated Refractory Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT01405807 Org: User:
Start: 02/28/11 End: 03/31/14 Due: 03/31/15

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00559858 Org: User:
Start: 12/31/04 End: - Due: -

Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation

Phase: N/A Priority: Normal
NCT ID: NCT06555757 Org: User:
Start: 08/15/24 End: 08/15/27 Due: 08/15/28

Pharmacological Management of Seizures Post Traumatic Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT04573803 Org: User:
Start: 03/01/21 End: 03/01/28 Due: 03/01/29

Assessment of BladderLight SurvEILlance

Phase: N/A Priority: Normal
NCT ID: NCT03427034 Org: User:
Start: 02/28/18 End: 03/31/20 Due: 03/31/21

Digital Imaging Versus Ophthalmoscopy

Phase: N/A Priority: Normal
NCT ID: NCT05282147 Org: User:
Start: 06/30/22 End: 12/31/25 Due: 12/31/26

PARTial BREast RECONstruction With Chest Wall Perforator Flap

Phase: N/A Priority: Normal
NCT ID: NCT06728527 Org: User:
Start: 06/01/23 End: 05/31/26 Due: 05/31/27

DiGESTnewborn Study

Phase: N/A Priority: Normal
NCT ID: NCT04192422 Org: User:
Start: 09/01/20 End: 12/31/26 Due: 12/31/27

DigiVis: Self-testing Vision App for Telephone Consultations

Phase: N/A Priority: Normal
NCT ID: NCT04482387 Org: User:
Start: 07/24/20 End: 08/01/21 Due: 08/01/22

HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)

Phase: N/A Priority: Normal
NCT ID: NCT04801940 Org: User:
Start: 05/19/21 End: 01/31/24 Due: 01/31/25

Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures

Phase: N/A Priority: Normal
NCT ID: NCT02129309 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

Phase: N/A Priority: Normal
NCT ID: NCT03449251 Org: User:
Start: 03/28/18 End: 09/30/25 Due: 09/30/26

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05131828 Org: User:
Start: 03/08/22 End: 05/31/25 Due: 05/31/26

APRIL (AbatacePt in Rheumatoid Arthritis-ILD)

Phase: N/A Priority: Normal
NCT ID: NCT03084419 Org: User:
Start: 06/26/18 End: 03/01/20 Due: 03/01/21

Comparison of DuoFertility, LadyComp/BabyComp and Clearblue Monitors

Phase: N/A Priority: Normal
NCT ID: NCT01364935 Org: User:
Start: 03/31/11 End: 05/31/14 Due: 05/31/15

Functional Exercise Response on osteoArthritis Relaxation Imaging

Phase: N/A Priority: Normal
NCT ID: NCT03657303 Org: User:
Start: 11/21/19 End: 12/31/22 Due: 12/31/23

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01093235 Org: User:
Start: 04/30/09 End: - Due: -

Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01712945 Org: User:
Start: 06/30/12 End: 10/31/17 Due: 10/31/18

Virtual Environment Rehabilitation for Patients With Motor Neglect Trial

Phase: N/A Priority: Normal
NCT ID: NCT03887962 Org: User:
Start: 05/01/17 End: 11/01/21 Due: 11/01/22